Zhen Su Email & Phone

Chief Executive Officer @ Marengo Therapeutics

Founding Chair, SITC Biotech Committee @ Society for Immunotherapy of Cancer (SITC)

Director Board of Directors @ CytomX Therapeutics

Co-Chair, SITC Industry Committee @ Society for Immunotherapy of Cancer (SITC)

Senior Vice President, Global Head of Oncology Business Francise @ Merck KGaA, Darmstadt, Germany

Chief Medical Officer of EMD Serono @ Merck KGaA, Darmstadt, Germany

SVP, Global Head of Oncology Medical @ Merck KGaA, Darmstadt, Germany

Vice President and Head of US Medical - Oncology @ Merck KGaA, Darmstadt, Germany

Director, Board of Directors @ Karyopharm Therapeutics Inc.

Director Board of Directors @ Galvanize Therapeutics, Inc.

Sr. Director, Global Clinical and Medical Lead, Jevtana @ Sanofi

Member Board of Directors @ Marengo Therapeutics

SITC Industry Committee Co-Chair @ Society for Immunotherapy of Cancer (SITC)

Senior Vice President, US and GLOBAL Head of Oncology Business Franchise @ Merck KGaA, Darmstadt, Germany

Associate Vice President and Global Program Head (General Manager) - Jevtana and Taxane Franchise @ Sanofi

Director, Clinical Development and Medical Affairs - Oncology and Respirology and Urology @ GSK

Assistant Professor GU Oncology; Director of Cancer Immunotherapy and Gene Therapy Program @ University of Florida

Assistant Professor, GU Oncology @ Duke University

- @ Duke University

- @ Technische Universität Dresden

2018 - @

Strategy, Medical Devices, Clinical Development, Biotechnology, Cancer Immunotherapy, Clinical Research, Medical Affairs, Healthcare, Customer Service, Pharmacology, Drug Discovery, Clinical Trials, Vaccines, Molecular Biology, Hematology, Cancer, Medical Writing, Business Strategy, Regulatory Submissions, Oncology, Regulatory Affairs, Clinical Study Design, Outcomes Research, Lifesciences, Urology, Immunology, Pharmacoeconomics, Pharmaceutical Industry, Medical Education, Medicine, Microsoft Office, Infectious Diseases, Strategic Planning, Hospitals, Marketing, Project Management

Zhen Su, based in Cambridge, MA, US, is currently a Chief Executive Officer at Marengo Therapeutics. Zhen Su brings experience from previous roles at Society for Immunotherapy of Cancer (SITC), CytomX Therapeutics, Society for Immunotherapy of Cancer (SITC), Merck KGaA, Darmstadt, Germany, Merck KGaA, Darmstadt, Germany, Merck KGaA, Darmstadt, Germany, Merck KGaA, Darmstadt, Germany, Karyopharm Therapeutics Inc., Galvanize Therapeutics, Inc., Sanofi, Marengo Therapeutics, Society for Immunotherapy of Cancer (SITC), Merck KGaA, Darmstadt, Germany, Sanofi, GSK, University of Florida, Duke University. Zhen Su holds various educational qualifications from Duke University. With a robust skill set that includes Strategy, Medical Devices, Clinical Development, Biotechnology, Cancer Immunotherapy, Zhen Su demonstrates proficiency in a wide range of areas.